PRRT2 and familial Mediterranean fever: Although our data suggest that a single clearly pathogenic MEFV variant is sufficient to confer to PKC inhibitors the ability to trigger inflammasome activation, our cohort of FMF patients is currently too small to draw robust conclusions regarding the number (biallelic mutations vs. mono‐allelic) of clearly pathogenic variants.